drugset / Trial / NCT01912391
Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
Selegiline is superior to placebo in improving psychological and physical functioning in patients with Borderline Personality Disorder.
Timeline
- Start
- 2012-10
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selegiline | Unknown | 12 mg | Other |